Skip to NavigationSkip to content

3rd Annual Oncology Market & Patient Access

Monday, December 13, 2010 - Tuesday, December 14, 2010
Barcelona, Spain

Event Type: Conference

This conference and networking event will present a fresh and original perspective on communicating the value and cost-effectiveness of high-value oncology drugs with payers, HTA assessors and other key stakeholders. Unlike other general pricing & reimbursement meetings which broadly discuss many therapeutic areas, this event will be focused specifically on the oncology marketplace. This conference will look at the latest innovative market access techniques as well as satisfying HTA requirements to build the right dossier.


Together with industry and non-industry decision-makers we will discuss the major elements which affect market and patient access in key markets: pay-for-performance schemes are being constantly reviewed and there are still implementation barriers. New technologies in the fields of personalised medicine, advanced diagnostics and supportive care are taking a bigger role in the decision making process. The opportunities which large emerging markets present, also require a better understanding of local stakeholders’ objectives, as well as local health economic drivers to obtain a better understanding of affordability. The negative fiscal economic environment dramatically impacts on companies, payers and patients as budget impact considerations become more crucial than ever.


All participants will experience real-life examples on how to deliver value to payers, as well as satisfying patient needs. By bringing multi-stakeholder perspectives into one room, this meeting will provide a balanced picture of oncology health economics today. By meeting policy makers and top industry figures that are designing or deciding on pricing & reimbursement models, attendees would be in a much better position to implement more-successful market access strategies, but also to provide life-improving therapies to patients in need.


Why attend?

  • Benchmark, network and co-operate with pharma & non-pharma decision makers.
  • Get up to date on innovative reimbursement schemes and their implementation.
  • View the global picture of oncology market access in Europe, USA and emerging markets.
  • Learn what data makes the difference for HTA agencies, regulators and payers and how to present it.
  • Understand the best ways to communicate value and achieve maximum patient and market access.
  • Hear multi-stakeholder perspectives from: pharmaceutical industry, academia, public insurers, HTA, policy-makers.
  • Understand how cancer drugs will be financed in the future.
  • Discover how payers are viewing risk-sharing agreements and what their initiatives in the field are.
  • Learn how market leaders are marketing oncology therapeutics in large emerging markets.

Who will benefit?

Pharmaceutical companies:
Vice-Presidents, Directors, Managers involved in oncology:
Pricing & Reimbursement, Health Economics & Outcomes, Government & Stakeholder Relations, Regulatory Affairs, Medical Affairs, Marketing, Therapy Area Heads, Market Access, Country Managers

Solution providers & consultants:
CEOs, Business Development, Senior Consultants
Independent Academics, Health Economists, Senior Doctors & Patient Representatives


Agenda request

To request the full agenda please follow the link:


Booking Information contact:

Erika Vavrovicova


Tel: +421 232 660 382

Fax: +421 232 660 397



Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches